Literature DB >> 7117685

Safe use of ursodeoxycholic acid in the treatment of dyspeptic symptoms in patients with chronic active hepatitis: a double-blind controlled trial.

C Del Vecchio Blanco, N Caporaso, S Gentile, M Rinaldi, R Pucci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7117685     DOI： 10.1177/030006058201000416

Source DB:  PubMed          Journal:  J Int Med Res        ISSN： 0300-0605            Impact factor:   1.671


× No keyword cloud information.
  4 in total

1.  Effects of ursodeoxycholic acid (UDCA) on serum liver damage indices in patients with chronic active hepatitis. A double-blind controlled study.

Authors:  E Rolandi; R Franceschini; A Cataldi; V Cicchetti; L Carati; T Barreca
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Gastric mucosal toxicity of duodenal juice constituents in the rat. Acute studies using ex vivo rat gastric chamber model.

Authors:  D Armstrong; E R Rytina; G M Murphy; R H Dowling
Journal:  Dig Dis Sci       Date:  1994-02       Impact factor: 3.199

Review 3.  Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546

Review 4.  Bile acids for viral hepatitis.

Authors:  W Chen; J Liu; C Gluud
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.